Author: Grossberg, Allison N.; Koza, Lilia A.; Ledreux, Aurélie; Prusmack, Chad; Krishnamurthy, Hari Krishnan; Jayaraman, Vasanth; Granholm, Ann-Charlotte; Linseman, Daniel A.
Title: A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients Cord-id: vtq2strs Document date: 2021_2_2
ID: vtq2strs
Snippet: The COVID-19 pandemic affects more than 81 million people worldwide with over 1.7 million deaths. As the population returns to work, it is critical to develop tests that reliably detect SARS-CoV-2-specific antibodies. Here we present results from a multiplex serology test for assessing the antibody responses to COVID-19. In an initial large cohort, this test shows greater than 99% agreement with COVID-19 PCR test. In a second outpatient cohort consisting of adults and children in Colorado, the I
Document: The COVID-19 pandemic affects more than 81 million people worldwide with over 1.7 million deaths. As the population returns to work, it is critical to develop tests that reliably detect SARS-CoV-2-specific antibodies. Here we present results from a multiplex serology test for assessing the antibody responses to COVID-19. In an initial large cohort, this test shows greater than 99% agreement with COVID-19 PCR test. In a second outpatient cohort consisting of adults and children in Colorado, the IgG responses are more robust in positive/symptomatic participants than in positive/asymptomatic participants, the IgM responses in symptomatic participants are transient and largely fall below the detection limit 30 days after symptom onset, and the levels of IgA against SARS-CoV-2 receptor binding domain are significantly increased in participants with moderate-to-severe symptoms compared to those with mild-to-moderate symptoms or asymptomatic individuals. Our results thus provide insight into serology profiling and the immune response to COVID-19.
Search related documents:
Co phrase search for related documents- active healthy and long patient term: 1
- active healthy and longitudinal study: 1
- active healthy and lymph node: 1
- acute infection and additional research: 1, 2, 3, 4, 5
- acute infection and additive model: 1, 2, 3, 4
- acute infection and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute infection and long patient term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute infection and long term immunity: 1, 2, 3, 4, 5, 6, 7, 8
- acute infection and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- acute infection and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute infection and lyme disease: 1, 2, 3
- acute infection and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acutely ill and additional research: 1
- acutely ill and long patient term: 1
- acutely ill and longitudinal study: 1, 2
- additional research and liver disease: 1, 2
- additional research and long patient term: 1
- additional research and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8
- additional research and lupus erythematosus: 1
Co phrase search for related documents, hyperlinks ordered by date